CIK 0001446159 · Non-accelerated filer<br>Smaller reporting company
AXE COMPUTE INC.
Sign in to watch- Ticker
- AGPU
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 331007393
- Phone
- 305-563-3850
- Business address
- 801 BRICKELL AVENUE, SUITE 510, MIAMI, FL, 33131
- Former names
- Predictive Oncology Inc., Precision Therapeutics Inc., Skyline Medical Inc., BioDrain Medical, Inc.
- Open-market buys, last 90 days
- $98,325
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$98,325. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-22 | JOHNSON DAVID O. Chief Operating Officer | Grant or award · Stock Options (right to buy) | +320,422 | 320,422 | ||
| 2017-06-22 | MYERS ROBERT L Chief Financial Officer | Grant or award · Stock Options (right to buy) | +304,110 | 304,110 | ||
| 2017-06-22 | GABRIEL RICHARD L Director | Grant or award · Stock Options (right to buy) | +125,000 | 125,000 | ||
| 2017-06-22 | McGoldrick Thomas J. Director | Grant or award · Stock Option (right to buy) | +199,830 | 199,830 | ||
| 2017-06-22 | KROCHUK TIMOTHY A Director | Grant or award · Stock Options (right to buy) | +125,000 | 125,000 | ||
| 2017-03-31 | Reding Andrew P. Director | Grant or award · Stock Option (right to buy) | +2,381 | 2,381 | ||
| 2017-03-31 | GABRIEL RICHARD L Director | Grant or award · Stock Options (right to buy) | +2,381 | 2,381 | ||
| 2017-03-31 | KROCHUK TIMOTHY A Director | Grant or award · Stock Options (right to buy) | +2,381 | 2,381 | ||
| 2017-03-31 | ENGLE J MELVILLE Director | Grant or award · Stock Options (right to buy) | +2,381 | 2,381 | ||
| 2017-03-31 | McGoldrick Thomas J. Director | Grant or award · Stock Option (right to buy) | +2,381 | 2,381 | ||
| 2017-03-31 | Schwartz Carl I. Chief Executive Officer | Grant or award · Stock Options (right to buy) | +2,381 | 2,381 | ||
| 2017-01-26 | Reding Andrew P. Director | Grant or award · Stock Option (right to buy) | +8,929 | 8,929 | ||
| 2017-01-26 | GABRIEL RICHARD L Director | Grant or award · Stock Options (right to buy) | +1,786 | 1,786 | ||
| 2017-01-26 | Schwartz Carl I. Chief Executive Officer | Grant or award · Stock Options (right to buy) | +7,143 | 7,143 | ||
| 2017-01-26 | Schwartz Carl I. Chief Executive Officer | Grant or award · Stock Options (right to buy) | +1,786 | 1,786 | ||
| 2017-01-26 | ENGLE J MELVILLE Director | Grant or award · Stock Options (right to buy) | +1,786 | 1,786 | ||
| 2017-01-26 | McGoldrick Thomas J. Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2017-01-26 | KROCHUK TIMOTHY A Director | Grant or award · Stock Options (right to buy) | +1,786 | 1,786 | ||
| 2016-09-16 | MYERS ROBERT L Chief Financial Officer | Grant or award · Stock Options (right to buy) | +89,339 | 89,339 | ||
| 2016-09-16 | JOHNSON DAVID O. Chief Operating Officer | Grant or award · Stock Options (right to buy) | +89,339 | 89,339 |
Page 18 of 20 · 384 trades